Skip to main content
Tourmaline Bio, Inc. logo

Tourmaline Bio, Inc. — Investor Relations & Filings

Ticker · TRML ISIN · US87410C1045 US Manufacturing
Filings indexed 336 across all filing types
Latest filing 2025-06-09 Report Publication Anno…
Country US United States of America
Listing US TRML

About Tourmaline Bio, Inc.

https://www.tourmalinebio.com/

Tourmaline Bio, Inc. is a late-stage clinical biotechnology company focused on developing transformative medicines for patients with life-altering inflammatory and immune diseases. The company's lead asset is pacibekitug, a monoclonal antibody that targets the interleukin-6 (IL-6) cytokine, a key driver of inflammation. Pacibekitug is being developed as a potential treatment for a range of conditions, with a primary focus on atherosclerotic cardiovascular disease (ASCVD) and other severe autoimmune and inflammatory disorders, aiming to establish a new standard of care in areas with high unmet medical need.

Recent filings

Filing Released Lang Actions
8-K
Report Publication Announcement Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 9, 2025. It primarily announces the availability of an updated corporate presentation (Exhibit 99.1) on the company's website and includes the presentation as an exhibit. The text explicitly states that the presentation is furnished and incorporated by reference but is not considered "filed" for certain regulatory purposes. The document does not contain detailed financial statements or substantive financial data but rather serves as a disclosure of a presentation update. Given the document length is 4024 characters (under 5000), and it announces the availability of a report (corporate presentation) rather than being the report itself, it fits the criteria for a Report Publication Announcement (RPA).
2025-06-09 English
FORM 4
Director's Dealing
2025-06-06 English
FORM 4
Director's Dealing
2025-06-06 English
FORM 4
Director's Dealing
2025-06-06 English
FORM 4
Director's Dealing
2025-06-06 English
FORM 4
Director's Dealing
2025-06-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.